All Press Releases
PILA PHARMA PUBLISHES INTERIM REPORT (1 July – 30 September 2023)
Malmö, 25 October, 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period July – September 2023. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/. SUMMARY OF INTERIM REPORT THIRD QUARTER (1 JULY – 30 SEPTEMBER 2023) Operating income amounted to TSEK 0 (281) The…
PILA PHARMA’S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 26.2 MILLION
Malmö, 25 October, 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…
CORRECTION: Clarification and extended information on previous press release regarding convertible loans and their structure.
Malmö, 24 August 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA), ("Pila Pharma" or the "Company") announces a correction regarding the press release "PILA PHARMA announces capital infusion via convertible loans" which was published earlier today, 24 August 2023. The correction refers to the fact that the press release lacked significant information on…